The FDA has approved Vivlodex (meloxicam) capsules, from Iroko Pharma, for the management of osteoarthritis pain in 5 mg and...
Iroko Pharmaceuticals announced that new data from a Phase III study in patients with osteoarthritis (OA) pain demonstrated patients treated...